Cubist Announces Appointment of Michael Tomsicek to Chief Financial Officer

  Cubist Announces Appointment of Michael Tomsicek to Chief Financial Officer

Business Wire

LEXINGTON, Mass. -- March 4, 2013

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the appointment of
Michael Tomsicek as Senior Vice President and Chief Financial Officer (CFO).
Mr. Tomsicek, who has served as Senior Vice President and Deputy CFO since
July 2012, succeeds David McGirr. After more than a decade of leadership at
Cubist, Mr. McGirr will serve as Senior Advisor to the Chief Executive Officer
(CEO), and retire in 2014.

Michael Tomsicek, Cubist CFO (Photo: Business Wire)

Michael Tomsicek, Cubist CFO (Photo: Business Wire)

“David has been an outstanding contributor to Cubist’s success over the past
decade,” said Mike Bonney, Cubist’s CEO. "He helped build the strong financial
foundation that Cubist and our shareholders benefit from today. We appreciate
his dedication to Cubist and are pleased he will continue to serve the Company
during this time of transition. In addition, a critical component of our
Building Blocks of Growth strategic goals has been cultivating top talent, and
we are very fortunate to have a successor in Michael who can step into this
important role and help continue our excellent momentum as we begin our next
chapter as a Company.”

Mr. McGirr said, "I’ve enjoyed working closely with Mike and everyone at
Cubist as CFO over the past decade and am proud to have helped the Company
become a global leader in the hospital and acute care environment, help
countless patients, and generate significant value for shareholders. I believe
now is the right time for a transition and am confident Michael will serve
Cubist very well as our CFO.”

“I have been fortunate to work closely with David to ensure a smooth
transition into my expanded role,” said Mr. Tomsicek. “With a strong financial
foundation, an exceptional late-stage pipeline, and an emerging global
presence, this is an exciting time at Cubist. I look forward to helping the
Company continue to grow and expand in the years ahead.”

As CFO, Mr. Tomsicek will oversee Cubist's financial planning and analysis,
technical accounting, controllership, treasury, tax, commercial financial
services, strategic sourcing activities, investor relations, and facilities
functions. Mr. Tomsicek joined Cubist in 2010 as Vice President of Corporate
Finance. Prior to Cubist, he spent eight years at General Electric Healthcare,
initially as Finance Manager of its global operations, and then as CFO of its
diagnostic ultrasound business and CFO of its global ultrasound product group.
Previously, Mr. Tomsicek served in a variety of financial and operational
roles at Motorola.

About Cubist

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
research, development, and commercialization of pharmaceutical products that
address significant unmet medical needs in the acute care environment. Cubist
is headquartered in Lexington, Mass. Additional information can be found at
Cubist’s web site at www.cubist.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130304005627/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50583003&lang=en

Contact:

Cubist Pharmaceuticals, Inc.
INVESTORS:
Eileen C. McIntyre, 781-860-8533
Vice President, Investor Relations
eileen.mcintyre@cubist.com
or
MEDIA:
Julie DiCarlo, 781-860-8063
Senior Director, Corporate Communications
julie.dicarlo@cubist.com
 
Press spacebar to pause and continue. Press esc to stop.